▲ +20.21% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for InnovAge in the last 3 months. The average price target is $29.80, with a high forecast of $32.00 and a low forecast of $26.00. The average price target represents a 20.21% upside from the last price of $24.79.
The current consensus among 6 investment analysts is to buy stock in InnovAge.
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, dental, mental health and psychiatric, meals, and activities, as well as physical, occupational, and speech therapy; transportation to the PACE center and third-party medical appointments; and care management. It serves approximately 6,600 PACE participants in the United States of America; and operates seventeen PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.